Table 5.
QALYs and costs (millions of dollars) associated with folic acid fortification, using alternative NTD and MI dose-response functionsa
| Annual QALY Gains | ||||||
|---|---|---|---|---|---|---|
| Strategyb | NTDs | MIs | CC | B-12 | Net QALY gain |
Annual net costs |
| No fortification | 0 | 0 | 0 | 0 | 0 | $0 |
| 140 mcg/100 g | 15,842 | 114,532 | 17,402 | −5 | 147,770 | −$2,154 |
| 350 mcg/100 g | 28,445 | 193,475 | 57,403 | −57 | 279,267 | −$3,958 |
| 700 mcg/100 g | 33,268 | 224,325 | 112,146 | −254 | 369,485 | −$5,078 |
NTD dose-response function assumes the following relative risks of NTD-affected pregnancy: 0.36; 0.50; and 0.65 for maternal folate intake of >400, 301-400, and 201-300 micrograms (mcg) per day, respectively, compared to ≤200 mcg/day. MI dose-response function assumes the following relative risks of MI: 0.59; 0.63; and 0.70 for folate intake of >400, 301-400, and 201-300 micrograms (mcg) per day, respectively, compared to ≤200 mcg/day.
Strategies labeled by amount of fortification in mcg of folic acid added per 100 g of enriched grain product.
QALYs, quality-adjusted-life-years; NTDs, neural tube defects; MIs, myocardial infarctions; CC, colon cancer; B-12, Vitamin B-12 masking; mcg, micrograms; g, grams